Lenacapavir long-acting: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 4 1 Not applicable 1

Condition	Trials
HIV	2
Contact With or Exposure to Human Immunodeficiency Virus	1
HIV Pre-exposure Prophylaxis	1
HIV Pre-exposure Prophylaxis Use	1
HIV Prevention	1
HIV Prevention Program	1
HIV Prevention and Care	1

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
NCT07218211 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
NCT07497594 · Phase: Not applicable (e.g. observational or device study) · Ages: 16 Years to 30 Years · Sex: All (male and female) · 8 locations

2 recruiting trials across 7 conditions.

No. For the full record, search ClinicalTrials.gov.